Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Nuvectis Pharma, Inc. (NVCT)

11.99   0.79 (7.05%) 07-02 19:09
Open: 11.0082 Pre. Close: 11.2
High: 11.99 Low: 10.43
Volume: 13,584 Market Cap: 152(M)
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12 - 12.06 12.06 - 12.12
Low: 10.31 - 10.36 10.36 - 10.42
Close: 11.89 - 11.99 11.99 - 12.09

Technical analysis

as of: 2022-07-01 4:24:04 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 16.38     One year: 19.43
Support: Support1: 9.8    Support2: 8.15
Resistance: Resistance1: 14.02    Resistance2: 16.63
Pivot: 11.35
Moving Average: MA(5): 11.84     MA(20): 11.56
MA(100): 10.52     MA(250): 0
MACD: MACD(12,26): -0.5     Signal(9): -0.6
Stochastic oscillator: %K(14,3): 48.2     %D(3): 51.4
RSI: RSI(14): 48.6
52-week: High: 20.92  Low: 3.41
Average Vol(K): 3-Month: 34 (K)  10-Days: 12 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ NVCT ] has closed below upper band by 27.3%. Bollinger Bands are 0% narrower than normal.

Headline News

Tue, 28 Jun 2022
Great week for Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders who have 58% stake and they haven’t stopped buying - Simply Wall St

Tue, 28 Jun 2022
Newstead villagers open JustGiving page to save Village Green - Border Telegraph

Tue, 21 Jun 2022
NVCT stock gains after FDA nod to start trials for cancer candidate (NASDAQ:NVCT) - Seeking Alpha

Mon, 13 Jun 2022
Nuvectis Pharma (NVCT) Stock: Why The Price Increased Over 3% Today - Pulse 2.0

Fri, 20 May 2022
Nuvectis Pharma to Present in the H.C. Wainwright Global Investment Conference - Yahoo Finance

Mon, 07 Feb 2022
Best Penny Stocks Today: Why NVCT Stock Is Moving 230%+ - Penny Stocks

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 3 (M)
% Held by Insiders 59.5 (%)
% Held by Institutions 15.3 (%)
Shares Short 42 (K)
Shares Short P.Month 40 (K)

Stock Financials

EPS 0
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) -609.8
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -10 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.